Cargando…
Isothiocyanates: cholinesterase inhibiting, antioxidant, and anti-inflammatory activity
Finding a new type of cholinesterase inhibitor that would overcome the brain availability and pharmacokinetic parameters or hepatotoxic liability has been a focus of investigations dealing with the treatment of Alzheimer’s disease. Isothiocyanates have not been previously investigated as potential c...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010089/ https://www.ncbi.nlm.nih.gov/pubmed/29513045 http://dx.doi.org/10.1080/14756366.2018.1442832 |